APO Research

APO RESEARCH · REPORT

Medical Morphine

Selected research

Industry Growth & Trends

Global Medical Morphine Industry Growth and Trends Forecast to 2032

Market perspective

The global Medical Morphine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Medical Morphine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Medical Morphine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Morphine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Medical Morphine include Sun Pharmaceutical Industries, Pfizer, Taj Pharmaceuticals Limited, Purdue Pharma, Mallinckrodt Pharmaceuticals and Alcaliber, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Medical Morphine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Medical Morphine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Medical Morphine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Medical Morphine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Medical Morphine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Medical Morphine Market by Company

Sun Pharmaceutical Industries

Pfizer

Taj Pharmaceuticals Limited

Purdue Pharma

Mallinckrodt Pharmaceuticals

Alcaliber

Medical Morphine Segment by Type

Oral

Injectables

Medical Morphine Segment by Application

Cancer

Arthritis

Medical Morphine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Morphine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Morphine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Morphine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Medical Morphine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Medical Morphine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Table 2. Major Company of Injectables Table 3. Global Medical Morphine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Medical Morphine Sales by Type (2021-2026) & (k units) Table 5. Global Medical Morphine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Medical Morphine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Medical Morphine Sales Market Share in Value by Type (2021-2026) Table 8. Global Medical Morphine Price by Type (2021-2026) & (US$/unit) Table 9. Global Medical Morphine Sales by Type (2027-2032) & (k units) Table 10. Global Medical Morphine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Medical Morphine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Medical Morphine Sales Market Share in Value by Type (2027-2032) Table 13. Global Medical Morphine Price by Type (2027-2032) & (US$/unit) Table 14. North America Medical Morphine Sales by Type (2021-2026) & (k units) Table 15. North America Medical Morphine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Medical Morphine Sales by Type (2021-2026) & (k units) Table 17. Europe Medical Morphine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Medical Morphine Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Medical Morphine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Medical Morphine Sales by Type (2021-2026) & (k units) Table 21. Latin America Medical Morphine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Medical Morphine Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Medical Morphine Sales by Type (2021-2026) & (US$ Million) Table 24. Medical Morphine Industry Trends Table 25. Medical Morphine Industry Drivers Table 26. Medical Morphine Industry Opportunities and Challenges Table 27. Medical Morphine Industry Restraints Table 28. Global Medical Morphine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Medical Morphine Revenue Market Share by Company (2021-2026) Table 30. Global Medical Morphine Sales by Company (2021-2026) & (k units) Table 31. Global Medical Morphine Sales Share by Company (2021-2026) Table 32. Global Medical Morphine Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Medical Morphine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Medical Morphine Major Company Production Sites and Headquarters Table 35. Global Medical Morphine Company, Product Type & Application Table 36. Global Medical Morphine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Medical Morphine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Medical Morphine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Medical Morphine Sales by Region (2021-2026) & (k units) Table 41. Global Medical Morphine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Medical Morphine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Medical Morphine Sales Market Share in Value by Region (2021-2026) Table 44. Global Medical Morphine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Medical Morphine Sales by Region (2027-2032) & (k units) Table 46. Global Medical Morphine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Medical Morphine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Medical Morphine Sales Market Share in Value by Region (2027-2032) Table 49. Global Medical Morphine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Medical Morphine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Medical Morphine Sales by Application (2021-2026) & (k units) Table 52. Global Medical Morphine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Medical Morphine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Medical Morphine Sales Market Share in Value by Application (2021-2026) Table 55. Global Medical Morphine Price by Application (2021-2026) & (US$/unit) Table 56. Global Medical Morphine Sales by Application (2027-2032) & (k units) Table 57. Global Medical Morphine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Medical Morphine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Medical Morphine Sales Market Share in Value by Application (2027-2032) Table 60. Global Medical Morphine Price by Application (2027-2032) & (US$/unit) Table 61. North America Medical Morphine Sales by Application (2021-2026) & (k units) Table 62. North America Medical Morphine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Medical Morphine Sales by Application (2021-2026) & (k units) Table 64. Europe Medical Morphine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Medical Morphine Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Medical Morphine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Medical Morphine Sales by Application (2021-2026) & (k units) Table 68. Latin America Medical Morphine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Medical Morphine Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Medical Morphine Sales by Application (2021-2026) & (US$ Million) Table 71. Sun Pharmaceutical Industries Company Information Table 72. Sun Pharmaceutical Industries Business Overview Table 73. Sun Pharmaceutical Industries Medical Morphine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Sun Pharmaceutical Industries Medical Morphine Product Portfolio Table 75. Sun Pharmaceutical Industries Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Medical Morphine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Pfizer Medical Morphine Product Portfolio Table 80. Pfizer Recent Development Table 81. Taj Pharmaceuticals Limited Company Information Table 82. Taj Pharmaceuticals Limited Business Overview Table 83. Taj Pharmaceuticals Limited Medical Morphine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Taj Pharmaceuticals Limited Medical Morphine Product Portfolio Table 85. Taj Pharmaceuticals Limited Recent Development Table 86. Purdue Pharma Company Information Table 87. Purdue Pharma Business Overview Table 88. Purdue Pharma Medical Morphine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Purdue Pharma Medical Morphine Product Portfolio Table 90. Purdue Pharma Recent Development Table 91. Mallinckrodt Pharmaceuticals Company Information Table 92. Mallinckrodt Pharmaceuticals Business Overview Table 93. Mallinckrodt Pharmaceuticals Medical Morphine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Mallinckrodt Pharmaceuticals Medical Morphine Product Portfolio Table 95. Mallinckrodt Pharmaceuticals Recent Development Table 96. Alcaliber Company Information Table 97. Alcaliber Business Overview Table 98. Alcaliber Medical Morphine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Alcaliber Medical Morphine Product Portfolio Table 100. Alcaliber Recent Development Table 101. North America Medical Morphine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 102. North America Medical Morphine Sales by Country (2021-2026) & (k units) Table 103. North America Medical Morphine Sales Market Share by Country (2021-2026) Table 104. North America Medical Morphine Sales Forecast by Country (2027-2032) & (k units) Table 105. North America Medical Morphine Sales Market Share Forecast by Country (2027-2032) Table 106. North America Medical Morphine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Medical Morphine Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Medical Morphine Market Share by Country (2021-2026) Table 109. North America Medical Morphine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Medical Morphine Market Share Forecast by Country (2027-2032) Table 111. Europe Medical Morphine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 112. Europe Medical Morphine Sales by Country (2021-2026) & (k units) Table 113. Europe Medical Morphine Sales Market Share by Country (2021-2026) Table 114. Europe Medical Morphine Sales Forecast by Country (2027-2032) & (k units) Table 115. Europe Medical Morphine Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Medical Morphine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Medical Morphine Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Medical Morphine Market Share by Country (2021-2026) Table 119. Europe Medical Morphine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Medical Morphine Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Medical Morphine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Medical Morphine Sales by Country (2021-2026) & (k units) Table 123. Asia-Pacific Medical Morphine Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Medical Morphine Sales Forecast by Country (2027-2032) & (k units) Table 125. Asia-Pacific Medical Morphine Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Medical Morphine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Medical Morphine Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Medical Morphine Market Share by Country (2021-2026) Table 129. Asia-Pacific Medical Morphine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Medical Morphine Market Share Forecast by Country (2027-2032) Table 131. Latin America Medical Morphine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Latin America Medical Morphine Sales by Country (2021-2026) & (k units) Table 133. Latin America Medical Morphine Sales Market Share by Country (2021-2026) Table 134. Latin America Medical Morphine Sales Forecast by Country (2027-2032) & (k units) Table 135. Latin America Medical Morphine Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Medical Morphine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Medical Morphine Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Medical Morphine Market Share by Country (2021-2026) Table 139. Latin America Medical Morphine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Medical Morphine Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Medical Morphine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Medical Morphine Sales by Country (2021-2026) & (k units) Table 143. Middle East and Africa Medical Morphine Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Medical Morphine Sales Forecast by Country (2027-2032) & (k units) Table 145. Middle East and Africa Medical Morphine Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Medical Morphine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Medical Morphine Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Medical Morphine Market Share by Country (2021-2026) Table 149. Middle East and Africa Medical Morphine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Medical Morphine Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Medical Morphine Distributors List Table 154. Medical Morphine Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Medical Morphine Image Figure 2. Global Medical Morphine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Morphine Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical Morphine Sales (2021-2032) & (k units) Figure 5. Oral Image Figure 6. Global Oral Sales YoY Growth (2021-2032) & (k units) Figure 7. Injectables Image Figure 8. Global Injectables Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Medical Morphine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Medical Morphine Market Share by Type 2025 VS 2032 Figure 11. North America Medical Morphine Sales Market Share in Volume by Type in 2025 Figure 12. North America Medical Morphine Sales Market Share in Value by Type in 2025 Figure 13. Europe Medical Morphine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Medical Morphine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Medical Morphine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Medical Morphine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Medical Morphine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Medical Morphine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Medical Morphine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Medical Morphine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Medical Morphine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cancer Image Figure 24. Global Cancer Sales YoY Growth (2021-2032) & (k units) Figure 25. Arthritis Image Figure 26. Global Arthritis Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Medical Morphine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Medical Morphine Market Share by Application 2025 VS 2032 Figure 29. North America Medical Morphine Sales Market Share in Volume by Application in 2025 Figure 30. North America Medical Morphine Sales Market Share in Value by Application in 2025 Figure 31. Europe Medical Morphine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Medical Morphine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Medical Morphine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Medical Morphine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Medical Morphine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Medical Morphine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Medical Morphine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Medical Morphine Sales Market Share in Value by Application in 2025 Figure 39. North America Medical Morphine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Medical Morphine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Medical Morphine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Medical Morphine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Medical Morphine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Medical Morphine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Medical Morphine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Medical Morphine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Medical Morphine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Medical Morphine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Medical Morphine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Medical Morphine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Medical Morphine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Medical Morphine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Medical Morphine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Medical Morphine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Medical Morphine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Medical Morphine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Medical Morphine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Medical Morphine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Medical Morphine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Medical Morphine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injectables
Applications
  • Cancer
  • Arthritis
Companies covered
  • Sun Pharmaceutical Industries
  • Pfizer
  • Taj Pharmaceuticals Limited
  • Purdue Pharma
  • Mallinckrodt Pharmaceuticals
  • Alcaliber

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Medical Morphine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Medical Morphine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Medical Morphine Market by Type
  6. 1.3.1 Oral
  7. 1.3.2 Injectables
  8. 1.4 Global Medical Morphine Market Size by Type
  9. 1.4.1 Global Medical Morphine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Medical Morphine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Medical Morphine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Medical Morphine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Medical Morphine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Medical Morphine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Medical Morphine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Medical Morphine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Medical Morphine Industry Trends
  2. 2.2 Medical Morphine Industry Drivers
  3. 2.3 Medical Morphine Industry Opportunities and Challenges
  4. 2.4 Medical Morphine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Medical Morphine Revenue (2021-2026)
  2. 3.2 Global Top Players by Medical Morphine Sales (2021-2026)
  3. 3.3 Global Top Players by Medical Morphine Price (2021-2026)
  4. 3.4 Global Medical Morphine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Medical Morphine Major Company Production Sites & Headquarters
  6. 3.6 Global Medical Morphine Company, Product Type & Application
  7. 3.7 Global Medical Morphine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Medical Morphine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Medical Morphine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Medical Morphine Tier 1, Tier 2, and Tier 3
4 Medical Morphine Regional Status and Outlook
  1. 4.1 Global Medical Morphine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Medical Morphine Historic Market Size by Region
  3. 4.2.1 Global Medical Morphine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Medical Morphine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Medical Morphine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Medical Morphine Forecasted Market Size by Region
  7. 4.3.1 Global Medical Morphine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Medical Morphine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Medical Morphine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Medical Morphine by Application
  1. 5.1 Medical Morphine Market by Application
  2. 5.1.1 Cancer
  3. 5.1.2 Arthritis
  4. 5.2 Global Medical Morphine Market Size by Application
  5. 5.2.1 Global Medical Morphine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Medical Morphine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Medical Morphine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Medical Morphine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Medical Morphine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Medical Morphine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Medical Morphine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Medical Morphine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sun Pharmaceutical Industries
  2. 6.1.1 Sun Pharmaceutical Industries Company Information
  3. 6.1.2 Sun Pharmaceutical Industries Business Overview
  4. 6.1.3 Sun Pharmaceutical Industries Medical Morphine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sun Pharmaceutical Industries Medical Morphine Product Portfolio
  6. 6.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Medical Morphine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Medical Morphine Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Taj Pharmaceuticals Limited
  14. 6.3.1 Taj Pharmaceuticals Limited Company Information
  15. 6.3.2 Taj Pharmaceuticals Limited Business Overview
  16. 6.3.3 Taj Pharmaceuticals Limited Medical Morphine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Taj Pharmaceuticals Limited Medical Morphine Product Portfolio
  18. 6.3.5 Taj Pharmaceuticals Limited Recent Developments
  19. 6.4 Purdue Pharma
  20. 6.4.1 Purdue Pharma Company Information
  21. 6.4.2 Purdue Pharma Business Overview
  22. 6.4.3 Purdue Pharma Medical Morphine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Purdue Pharma Medical Morphine Product Portfolio
  24. 6.4.5 Purdue Pharma Recent Developments
  25. 6.5 Mallinckrodt Pharmaceuticals
  26. 6.5.1 Mallinckrodt Pharmaceuticals Company Information
  27. 6.5.2 Mallinckrodt Pharmaceuticals Business Overview
  28. 6.5.3 Mallinckrodt Pharmaceuticals Medical Morphine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mallinckrodt Pharmaceuticals Medical Morphine Product Portfolio
  30. 6.5.5 Mallinckrodt Pharmaceuticals Recent Developments
  31. 6.6 Alcaliber
  32. 6.6.1 Alcaliber Company Information
  33. 6.6.2 Alcaliber Business Overview
  34. 6.6.3 Alcaliber Medical Morphine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Alcaliber Medical Morphine Product Portfolio
  36. 6.6.5 Alcaliber Recent Developments
7 North America by Country
  1. 7.1 North America Medical Morphine Sales by Country
  2. 7.1.1 North America Medical Morphine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Medical Morphine Sales by Country (2021-2026)
  4. 7.1.3 North America Medical Morphine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Medical Morphine Market Size by Country
  6. 7.2.1 North America Medical Morphine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Medical Morphine Market Size by Country (2021-2026)
  8. 7.2.3 North America Medical Morphine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Medical Morphine Sales by Country
  2. 8.1.1 Europe Medical Morphine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Medical Morphine Sales by Country (2021-2026)
  4. 8.1.3 Europe Medical Morphine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Medical Morphine Market Size by Country
  6. 8.2.1 Europe Medical Morphine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Medical Morphine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Medical Morphine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Medical Morphine Sales by Country
  2. 9.1.1 Asia-Pacific Medical Morphine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Medical Morphine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Medical Morphine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Medical Morphine Market Size by Country
  6. 9.2.1 Asia-Pacific Medical Morphine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Medical Morphine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Medical Morphine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Medical Morphine Sales by Country
  2. 10.1.1 South America Medical Morphine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Medical Morphine Sales by Country (2021-2026)
  4. 10.1.3 South America Medical Morphine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Medical Morphine Market Size by Country
  6. 10.2.1 South America Medical Morphine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Medical Morphine Market Size by Country (2021-2026)
  8. 10.2.3 South America Medical Morphine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Medical Morphine Sales by Country
  2. 11.1.1 Middle East and Africa Medical Morphine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Medical Morphine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Medical Morphine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Medical Morphine Market Size by Country
  6. 11.2.1 Middle East and Africa Medical Morphine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Medical Morphine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Medical Morphine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Medical Morphine Value Chain Analysis
  2. 12.1.1 Medical Morphine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Medical Morphine Production Mode & Process
  7. 12.2 Medical Morphine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Medical Morphine Distributors
  10. 12.2.3 Medical Morphine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research